Telomere biology disorders in childhood interstitial lung disease: new insights from the chILD-EU cohort

Greiner-Mai et al. expand recognition of telomere biology disorder (TBD)-associated interstitial lung disease (ILD) in children, demonstrating heterogenous radiographic and ILD subtypes in combination with variable extrapulmonary phenotypes, even in the absence of ultrashort peripheral blood telomere length (TL).While their findings highlight some of the limitations of current TL testing methods, they introduce critical questions regarding family screening and the role of antifibrotic and telomeredirected therapies in children with TBD-related ILD.Despite being first described in children, the pulmonary manifestations of telomere biology disorders (TBDs) have been better studied in adults with interstitial lung disease (ILD).Between 15%-30% of adults with familial ILD have short telomeres (<10th age adjusted percentile), pathogenic or likely pathogenic telomere maintenance gene variants, or both (Table 1). 1) In contrast, the association between TBD and childhood ILD has been less well described.In this setting, the cohort study from Greiner-Mai et al. adds a significant international perspec tive. 2)Using the chILD-EU database, the authors measured telomere length (TL) by quantitative polymerase chain reaction (qPCR) and completed exome sequencing to identify pediatric patients with TBD-related ILD, which they characterized as the presence of a pathogenic variant or variant of unknown significance (VUS), with phenotypic manifestations of a TBD, with or without TL <10th percentile.This inclusive definition captures the complexity of genotype-phenotype relationships in TBDs, including that ultrashort TL can be inherited independently of the causative genetic variant and that TL can be shorter in affected tissues, even if peripheral blood mononuclear cells (PBMC) have TL>10th percentile.Greiner-Mai et al. 2) identified 10 pediatric patients within chILD-EU with TBD ILD.While the denominator is not reported, given the size of the data base presented

Authors

Institutions

Publication Details

Journal
Clinical and Experimental Pediatrics
Published
2026-06-30
DOI
https://doi.org/10.3345/cep.2026.01389
Primary Topic
Telomeres, Telomerase, and Senescence
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Telomere biology disorders in childhood interstitial lung disease: new insights from the chILD-EU cohort

Andrew Courtwright
Clinical and Experimental Pediatrics
Telomeres, Telomerase, and Senescence
article

Telomere biology disorders in childhood interstitial lung disease: new insights from the chILD-EU cohort

Andrew Courtwright
article en

Abstract

Greiner-Mai et al. expand recognition of telomere biology disorder (TBD)-associated interstitial lung disease (ILD) in children, demonstrating heterogenous radiographic and ILD subtypes in combination with variable extrapulmonary phenotypes, even in the absence of ultrashort peripheral blood telomere length (TL).While their findings highlight some of the limitations of current TL testing methods, they introduce critical questions regarding family screening and the role of antifibrotic and telomeredirected therapies in children with TBD-related ILD.Despite being first described in children, the pulmonary manifestations of telomere biology disorders (TBDs) have been better studied in adults with interstitial lung disease (ILD).Between 15%-30% of adults with familial ILD have short telomeres (<10th age adjusted percentile), pathogenic or likely pathogenic telomere maintenance gene variants, or both (Table 1). 1) In contrast, the association between TBD and childhood ILD has been less well described.In this setting, the cohort study from Greiner-Mai et al. adds a significant international perspec tive. 2)Using the chILD-EU database, the authors measured telomere length (TL) by quantitative polymerase chain reaction (qPCR) and completed exome sequencing to identify pediatric patients with TBD-related ILD, which they characterized as the presence of a pathogenic variant or variant of unknown significance (VUS), with phenotypic manifestations of a TBD, with or without TL <10th percentile.This inclusive definition captures the complexity of genotype-phenotype relationships in TBDs, including that ultrashort TL can be inherited independently of the causative genetic variant and that TL can be shorter in affected tissues, even if peripheral blood mononuclear cells (PBMC) have TL>10th percentile.Greiner-Mai et al. 2) identified 10 pediatric patients within chILD-EU with TBD ILD.While the denominator is not reported, given the size of the data base presented

Clinical and Experimental PediatricsVol. 69(7)
University of Utah (US), Utah Department of Health (US)
Openalex Percentile: Top 8%
Telomeres, Telomerase, and Senescence
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.